Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.

Goertsches R, Baranzini SE, Morcillo C, Nos C, Camiña M, Oksenberg JR, Montalban X, Comabella M.

Mult Scler. 2008 Apr;14(3):412-4. doi: 10.1177/1352458507083780. Epub 2008 Jan 21.

PMID:
18208870
2.

Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.

Camiña-Tato M, Fernández M, Morcillo-Suárez C, Navarro A, Julià E, Edo MC, Montalban X, Comabella M.

J Neuroimmunol. 2010 May;222(1-2):70-5. doi: 10.1016/j.jneuroim.2010.03.003. Epub 2010 Apr 2.

PMID:
20363033
3.

Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.

Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA.

J Neurol Sci. 2002 Oct 15;202(1-2):93-7.

PMID:
12220699
4.

Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.

Pulkkinen K, Luomala M, Kuusisto H, Lehtimäki T, Saarela M, Jalonen TO, Elovaara I.

Acta Neurol Scand. 2004 May;109(5):342-7.

PMID:
15080861
5.

A polymorphism in the repetitive (TGGA)n sequence 5' to the human myelin basic protein gene in Italian multiple sclerosis patients.

Guerini FR, Losciale L, Mediati M, Speciale L, Mancuso R, Saresella M, Calvo MG, Caputo D, Ferrante P.

J Neurovirol. 2000 May;6 Suppl 2:S28-32.

PMID:
10871781
6.

Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.

Matesanz F, Fedetz M, Collado-Romero M, Fernández O, Guerrero M, Delgado C, Alcina A.

J Neuroimmunol. 2001 Sep 3;119(1):101-5.

PMID:
11525806
7.

Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis.

Cunningham S, Patterson CC, McDonnell G, Hawkins S, Vandenbroeck K.

Genes Immun. 2005 May;6(3):265-70.

PMID:
15729363
8.

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.

Ramil E, Sánchez AJ, González-Pérez P, Rodríguez-Antigüedad A, Gómez-Lozano N, Ortiz P, Arroyo R, De las Heras V, Vilches C, García-Merino A.

Mult Scler. 2010 Feb;16(2):139-46. doi: 10.1177/1352458509355071. Epub 2009 Dec 9.

PMID:
20007426
9.

An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis.

McDonnell GV, Kirk CW, Hawkins SA, Graham CA.

J Neurol Sci. 2000 May 1;176(1):4-12.

PMID:
10865086
10.

Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.

Otaegui D, Zuriarrain O, Castillo-Triviño T, Aransay A, Ruíz-Martinez J, Olaskoaga J, Marti-Masso J, Lopez de Munain A.

Mult Scler. 2009 Jan;15(1):124-8. doi: 10.1177/1352458508096682. Epub 2008 Aug 28.

PMID:
18755822
11.

Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?

Kauffman MA, Morón DG, Sandoval G, Sica RE, Garcea O, Villa AM.

Medicina (B Aires). 2007;67(5):436-8.

PMID:
18051225
12.

Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?

Sidoti A, Antognelli C, Rinaldi C, D'Angelo R, Dattola V, Girlanda P, Talesa V, Amato A.

Mult Scler. 2007 May;13(4):446-53.

PMID:
17463067
13.

PAI and TPA gene polymorphisms in multiple sclerosis.

Lovrecic L, Ristić S, Starcević-Cizmarević N, Brajenović-Milić B, Jazbec SS, Sepcić J, Kapović M, Peterlin B.

Mult Scler. 2008 Mar;14(2):243-7. Epub 2007 Nov 6.

PMID:
17986506
14.

Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.

Gillett A, Thessen Hedreul M, Khademi M, Espinosa A, Beyeen AD, Jagodic M, Kockum I, Harris RA, Olsson T.

Mult Scler. 2010 Sep;16(9):1056-65. doi: 10.1177/1352458510364634. Epub 2010 Mar 30.

PMID:
20354066
15.

Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.

Losonczi E, Bencsik K, Nagy ZF, Honti V, Szalczer E, Rajda C, Illés Z, Mátyás K, Rózsa C, Csépány T, Füvesi J, Vécsei L.

J Neuroimmunol. 2009 Mar 31;208(1-2):115-8. doi: 10.1016/j.jneuroim.2009.01.004. Epub 2009 Feb 6.

PMID:
19201038
16.

Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.

Hackstein H, Bitsch A, Bohnert A, Hofmann H, Weber F, Ohly A, Linington C, Mäurer M, Poser S, Rieckmann P, Bein G.

J Neuroimmunol. 2001 Feb 15;113(2):240-8.

PMID:
11164908
17.

Progression in familial and nonfamilial MS.

Koch M, Uyttenboogaart M, Heerings M, Heersema D, Mostert J, De Keyser J.

Mult Scler. 2008 Apr;14(3):300-6. doi: 10.1177/1352458507084269. Epub 2008 Jan 21.

PMID:
18208881
18.

3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis.

Illes Z, Safrany E, Peterfalvi A, Magyari L, Farago B, Pozsonyi E, Rozsa C, Komoly S, Melegh B.

Neurosci Lett. 2008 Jan 24;431(1):36-8. doi: 10.1016/j.neulet.2007.11.015. Epub 2007 Nov 17.

PMID:
18180107
19.

An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.

Gray OM, Abdeen H, McDonnell GV, Patterson CC, Graham CA, Hawkins SA.

Mult Scler. 2009 Mar;15(3):299-303. doi: 10.1177/1352458508099611.

PMID:
19244395
20.

The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.

Kroner A, Grimm A, Johannssen K, Mäurer M, Wiendl H.

Hum Immunol. 2007 May;68(5):422-5. Epub 2007 Feb 15.

PMID:
17462509

Supplemental Content

Support Center